
Educating parents of pediatric patients starts with getting staff on the same page.

Prescriptions with semaglutide (Wegovy, Ozempic, Novo Nordisk) are FDA approved to treat obesity and type 2 diabetes, respectively.

Ambient listening and transcription provide promising impact on the patient care experience.

The UOA offers networking opportunities with over 140,000 spectacle and contact lens opticians.

FYSX is the first non-pharmacological, non-surgical treatment designed to lower IOP for glaucoma patients, according to a news release.

What to know about evolving guidelines and potential medicolegal risks.

Pediatric TINU syndrome is rare, but responds well to treatment.

The survey found that most participants may not know that their symptoms could be associated with eye dryness, including redness, fluctuating vision, a scratch, gritty, tired, or heavy feeling in the eye, or overall eye irritation.

Catch up on what happened in optometry during the week of July 1-July 5.

According to Genentech, faricimab-svoa is the first and only syringe that is prefilled with an FDA-approved bispecific antibody to treat wet AMD, DME and RVO.

Belkin Vision is the developer of Vision Eagle direct selective laser trabeculoplasty technology.

Aiming to address long-standing challenges without sacrificing accuracy.

The company also submitted a marketing authorization application with the European Medicines Agency.

Notal Vision’s device was given to 15 patients to track changes in their neovascular age-related macular degeneration for the study.

Apellis will seek re-examination from the CHMP following the opinion, according to a news release.

Reflecting on big optometric wins keeps eye care in perspective.

Optometrists from the Union of Professional and Technical Employees CWA Local 9119 held a strike protesting the University of California's "bad-faith" bargaining practices earlier this year.

IKA Keratoconus Symposium and Controversies in Modern Eye Care shone brightly in May.

Catch up on what happened in optometry during the week of June 24-June 28.

Charissa Lee, OD, MBA, FAAO weighs in on the important role a diversity, equity, and inclusion perspective can play in leadership roles in optometry.

The company expects enrollment of the GAZE phase 1, open-label clinical trial, to begin in the second half of 2024.

Mandy Sallach, OD, overviews initiatives being taken on by the company to combat pediatric myopia.

As part of the sports and performance vision section of the AOA, Vittorio Mena, OD, MS, shares information on how to bolster athletes' performance through enhanced vision care.

Spencer Johnson, OD, FAAO, overviews his talk that gives the best practices for pre- and post-operative management for laser procedures like YAG capsulotomy, peripheral iridotomy, and selective laser trabeculoplasty.

Respecting the clinical importance of the pachychoroid spectrum is vital when analyzing OCT scans.

The organization's past-president and treasurer give some insights on what to expect at the 2024 Congress event this October.

Ring-IT was designed using a 3D printed model of a rigid plastic ring clip, and manufactured at Maker Health Space Medical Fabrication Laboratory at the University of Texas Medical Branch at Galveston.

The art of scleral lens fitting is coupled with a patient's patience as they neuro-adapt, according to Clark Chang, OD, MSA, MSc, FAAO.

Ruth Shoge, OD, MPH, FAAO, outlines what it means to identify ACES in pediatric patients.

Derek Bryant, incoming AOSA president, is excited about the future of optometry and is dedicated to empowering students to lead and advocate for the profession.